Explore News
-
1 in 4 Pancreatic Tumors Respond to New Therapy
A radical new treatment approach once deemed unfeasible has shown unprecedented success in shrinking pancreatic…
-
FDA Opens Early Access to Daraxonrasib for 8,000 PDAC Patients
The FDA’s move to expand access to daraxonrasib offers new hope for patients with metastatic…
